Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

68° Partly Cloudy

Site search

Home
News
- Local News
Sports
Obituaries
e-Edition
Classifieds
Explore the Sheyenne
Archives
Best of 2026

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.92 -0.07 (-0.58%)

Delayed Quote Updated: 11:35 AM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript ↗

October 08, 2026

Medtech segment surges 13.2% as NanoKnife prostate procedures hit record volumes.

Via The Motley Fool

Topics Earnings World Trade

Why AngioDynamics Crashed Today ↗

October 08, 2026

AngioDynamics beats earnings, and drops 20%.

Via The Motley Fool

Traders are paying attention to the gapping stocks in Thursday's session. ↗

October 08, 2026

Via Chartmill

AngioDynamics (NASDAQ:ANGO) Posts Narrower Q1 Loss, Holds Guidance Below Consensus ↗

October 08, 2026

Via Chartmill

AngioDynamics (NASDAQ:ANGO) Surges on Strong Quarterly Beat as Med Tech Segment Drives Growth ↗

July 14, 2026

Via Chartmill

AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance ↗

April 02, 2026

Via Chartmill

AngioDynamics Inc. (NASDAQ:ANGO) Reports Narrowed Loss and Revenue Beat in Q2 ↗

January 06, 2026

Via Chartmill

AngioDynamics Q1 Earnings Call Highlights ↗

October 08, 2026

AngioDynamics (NASDAQ:ANGO) reported fiscal 2027 first-quarter revenue growth of 6.9% to $80.9 million, led by continued expansion in its Med Tech segment, while the company maintained its full-year...

Via MarketBeat

Topics Earnings

AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027 ↗

August 11, 2026

AngioDynamics (NASDAQ:ANGO) expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear shift away from slower-growth legacy markets and...

Via MarketBeat

AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript ↗

July 21, 2026

Med Tech revenue surged 16.7% as company shifts toward higher-margin products.

Via The Motley Fool

Topics Earnings World Trade

AngioDynamics Q4 Earnings Call Highlights ↗

July 14, 2026

AngioDynamics (NASDAQ:ANGO) reported higher fiscal fourth-quarter and full-year revenue, driven by continued growth in its med tech portfolio, while management said the company remains focused on...

Via MarketBeat

Topics Earnings

Full Transcript: AngioDynamics Q4 2026 Earnings Call ↗

July 14, 2026

AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For...

Via Benzinga

Topics Earnings

Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability

April 02, 2026

The medical technology sector has long been a bellwether for the health of the broader economy and the efficiency of the healthcare system. Today, April 2, 2026, AngioDynamics (NASDAQ:ANGO) provided...

Via MarketMinute

Topics Economy Retirement

Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗

February 27, 2026

Parsons delivers technology-driven solutions for defense, intelligence, and critical infrastructure clients across North America and beyond.

Via The Motley Fool

AngioDynamics (ANGO) Q1 2026 Earnings Transcript ↗

January 06, 2026

AngioDynamics (ANGO) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

AngioDynamics (ANGO) Q3 2025 Earnings Transcript ↗

January 06, 2026

AngioDynamics (ANGO) Q3 2025 Earnings Transcript

Via The Motley Fool

AngioDynamics (ANGO) Q1 2025 Earnings Transcript ↗

January 06, 2026

AngioDynamics (ANGO) Q1 2025 Earnings Transcript

Via The Motley Fool

Topics Economy

AngioDynamics (ANGO) Q2 2026 Earnings Transcript ↗

January 06, 2026

AngioDynamics (ANGO) Q2 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Why AngioDynamics Stock Is Sinking Today ↗

January 06, 2026

An unexpected departure at the top is overshadowing a positive quarterly update for AngioDynamics.

Via The Motley Fool

Topics Retirement

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million ↗

November 04, 2025

Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million

Via The Motley Fool

Topics Regulatory Compliance

Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? ↗

November 04, 2025

Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank?

Via The Motley Fool

AngioDynamics Eyes Growth Despite Tariffs ↗

October 03, 2025

AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected.

Via Benzinga

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher ↗

October 02, 2025

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500...

Via Benzinga

Topics Stocks

Why Did AngioDynamics Stock Pop Today? ↗

October 02, 2025

Even 37 years after its founding, AngioDynamics still can't earn a profit.

Via The Motley Fool

What's Fueling The Momentum In AngioDynamics Stock? ↗

October 02, 2025

Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter.

Via Benzinga

Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results ↗

October 02, 2025

Via Benzinga

AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook ↗

October 02, 2025

AngioDynamics (ANGO) beat Q1 FY2026 earnings and revenue estimates, driven by strong Med Tech growth. The company also raised its full-year financial outlook.

Via Chartmill

Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗

October 02, 2025

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed.

Via Benzinga

Topics Stocks

S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗

October 02, 2025

CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

times-online.com
146 Third St. N.E.
Valley City, ND 58072
Phone: 701-845-0463
Email: editor@times-online.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

Headline News about AngioDynamics, Inc. - Common Stock

Sections

Services

Follow Us